w. mark saltzman yale university [email protected] biomaterials, drug delivery, and tissue...
TRANSCRIPT
W. Mark Saltzman
Yale [email protected]
http://saltzman.eng.yale.edu/research.html
Biomaterials, Drug Delivery, and Tissue Engineering
Biomaterials for Controlled Release of Drugs
Time (day)
00 4 8 12 16
0.2
0.4
0.6
0.8
Cum
ulat
ive
Dru
g R
elea
sed
PLGA nanoparticles loaded with camptothecin (CPT). Scale bar: 500 nm.
Sawyer, Saucier-Sawyer, Booth, Liu, Patel, Piepmeier, Saltzman (2011)
Brem, Colvin, Langer, Saltzman, and Guilford Pharmaceuticals (1990-2006): Gliadel ® approved for glioblastoma multiforme (1996)
Sawyer, Saucier-Sawyer, Booth, Liu, Patel, Piepmeier, Saltzman (2011)
Nanoparticles Loaded with Genetic Material
DNA: Pharm Res 16:1300, 1999; J Cont Rel 129:66, 2008;Nanomedicine 6:334, 2010;Nature Materials 11:82, 2012
siRNA: Nature Materials 8:526, 2009; Biomaterials 32:6194, 2011; Biomaterials 33:583, 2012
Peptide Nucleic Acids: Molecular Therapy 19:172, 2011Molecular Pharmaceutics 9:1481, 2012 Zhou, Patel, Fu, Bertram, and Saltzman (2012)
Tissue Engineering: Transplantable materials that turn into vascularized tissues
Human endothelial cells
Polymer microparticles loaded with proteins that stimulate blood vessel growth
Suspend in a Collagen Gel
Implant into a location in the body where new blood vessels are needed
With Jordan Pober, Immunobiology